The ITA, on behalf of IRONMAN, hereby reports that Brazil athlete Derik Felix Afornali has committed an anti-doping rule violation (ADRV) under article 2.1 of the IRONMAN Anti-Doping Rules (IRONMAN ADR) for the presence of clomifene in a sample collected out-of-competition by IRONMAN on 4 October 2022.
The sample collected from Derik Felix Afornali returned an adverse analytical finding for the specified prohibited substance clomifene. Clomifene is prohibited under the World Anti-Doping Agency’s Prohibited List as hormone and metabolic modulator (S4.2). Clomifene has the potential effects of boosting or restoring testosterone production and thus increasing muscle mass.
Derik Felix Afornali did not challenge the ADRV and agreed with the consequences proposed by the ITA. A two year period of ineligibility is the standard sanction for specified substances. Accordingly, this case was resolved via an acceptance of consequences pursuant to article 8.3.1 of the IRONMAN ADR. The athlete’s period of ineligibility across all sports ran until 3 October 2024 and any competition results obtained by the athlete after the positive test of 4 October 2022 are disqualified.